R&D Systems™ Recombinant Human Thrombopoietin (E. coli-expressed)

Description

A key regulator of megakaryocytopoiesis and thrombopoiesis

The Recombinant Human Thrombopoietin (E. coli-expressed) is derived from E. coli. The Recombinant Human Thrombopoietin (E. coli-expressed) has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: NP_000451
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 7066
• Molecular Weight (g/mol): 18.7 kDa
• Purification Method: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining
• Quantity: 10 μg
• Source: E. coli-derived human Thrombopoietin/Tpo protein Ser22-Leu195
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, ≤ -20°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 100 μg/mL in PBS
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose